How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Cell Culture Vessel Market
- By Product Type: T-flasks, Multi-layer Cell Culture Flasks, Cell Culture Plates, Cell Culture Dishes, Cell Culture Bags
- By Material: Polystyrene (PS), Polycarbonate (PC), Polypropylene (PP), Glass
- By Surface Treatment: Tissue Culture Treated (TC-treated), Non-treated, Collagen Coated, Extracellular Matrix Coated
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals and Diagnostic Laboratories
- By Application: Vaccine Production, Monoclonal Antibody Production, Stem Cell Research, Drug Discovery and Development, Tissue Engineering
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - T-flasks leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Cell Culture Vessel Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 4
Surface Treatment 4
End User 4
Application 5
Companies profiled
Corning Incorporated
Thermo Fisher Scientific Inc.
Sartorius AG
Merck KGaA (MilliporeSigma)
Greiner Bio-One International GmbH
Nunc (part of Thermo Fisher Scientific)
CELLSTAR (Greiner Bio-One)
SPL Life Sciences
Eppendorf AG
TPP Techno Plastic Products AG
Simport Scientific Ltd.
CytoOne
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nunc (part of Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →CELLSTAR (Greiner Bio-One)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →SPL Life Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Eppendorf AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →TPP Techno Plastic Products AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Simport Scientific Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →CytoOne
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Orange Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,048M by 2033 · 8.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- T-flasks41.1
- Multi-layer Cell Culture Flasks18.9
- Cell Culture Plates21.1
- Cell Culture Dishes7.8
- Cell Culture Bags11.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$716.7M → $1,224M · 6.9%
Europe$499.5M → $860.9M · 7.0%
Asia Pacific$456.1M → $831.2M · 7.8%
Latin America$282.3M → $471.0M · 6.6%
Middle East and Africa$217.2M → $438.2M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.052026
8.052027
8.072028
8.082029
8.092030
8.112031
8.132032
8.132033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Corning Incorporated23.2
- Thermo Fisher Scientific Inc.7.5
- Sartorius AG10.3
- Merck KGaA (MilliporeSigma)12.0
- Greiner Bio-One International GmbH8.1
- Nunc (part of Thermo Fisher Scientific)10.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type10.7%
Material18.0%
Surface Treatment18.8%
End User25.6%
Application26.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe22.5
- Asia Pacific21.7
- Latin America12.3
- Middle East and Africa11.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Corning Incorporated | 84 | 81 | 76 | 73 | 81 | 81 | 79 |
| Thermo Fisher Scientific Inc. | 75 | 72 | 93 | 80 | 90 | 81 | 82 |
| Sartorius AG | 75 | 65 | 88 | 80 | 62 | 81 | 75 |
| Merck KGaA (MilliporeSigma) | 61 | 65 | 82 | 80 | 69 | 81 | 73 |
| Greiner Bio-One International GmbH | 67 | 64 | 62 | 51 | 53 | 70 | 61 |
| Nunc (part of Thermo Fisher Scientific) | 63 | 54 | 66 | 55 | 52 | 49 | 57 |
| CELLSTAR (Greiner Bio-One) | 44 | 42 | 42 | 50 | 50 | 59 | 48 |
| SPL Life Sciences | 36 | 54 | 45 | 58 | 55 | 54 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Corning Incorporated
- Thermo Fisher Scientific Inc.
- Sartorius AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Corning Incorporated | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific Inc. | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Sartorius AG | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Merck KGaA (MilliporeSigma) | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Greiner Bio-One International GmbH | ◐ | ◐ | − | − | − | ✓ |
| Nunc (part of Thermo Fisher Scientific) | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| CELLSTAR (Greiner Bio-One) | − | − | − | − | − | ◐ |
| SPL Life Sciences | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific Inc.82
2Corning Incorporated79
3Sartorius AG75
4Merck KGaA (MilliporeSigma)73
5Greiner Bio-One International GmbH61
6Nunc (part of Thermo Fisher Scientific)57
7SPL Life Sciences50
8CELLSTAR (Greiner Bio-One)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Corning IncorporatedThermo Fisher Scientific Inc.
Challenger2
Strong scale, closing on the leaders.
Sartorius AGMerck KGaA (MilliporeSigma)
Contender2
Focused players with pockets of strength.
Greiner Bio-One International GmbHNunc (part of Thermo Fisher Scientific)
Niche2
Specialists in a single segment or region.
CELLSTAR (Greiner Bio-One)SPL Life Sciences
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Cell Culture Vessel Market — a $235M beachhead inside a $4.39B market.
Beachhead (SOM)$235Mobtainable near-term
Serviceable (SAM)$1.49Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
T-flasks
Best fit — highest urgency & budget in Product Type.
Economic buyer75 fit
Multi-layer Cell Culture Flasks
Strong fit — clear ROI and a fast path to value.
End user66 fit
Cell Culture Plates
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Surface Treatment
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve18%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Cell Culture Vessel Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified21%
Evaluation11%
Closed-won6%
$9.1KCAC
$50KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Cell Culture Vessel Market is a durable-growth opportunity — $8.65B by 2033, compounding at 8.6%.
TAM · 2025$4.46Btoday
TAM · 2033$8.65Bforecast
CAGR8.6%2027–2033
Cumulative$57.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.65BTotal addressable market
SAM$3.14BServiceable available market
SOM$519MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.65BLarge & growingTAM by 2033 at 8.6% CAGR
$3.14BServiceable nowreachable with today’s model
$519MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.75BBear5.6% CAGR
$8.65BBase8.6% CAGR
$11.1BBull11.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Cell Culture Vessel Market — a $7.48B market by 2033. Plan: grow share from 9.6% to 17.9%.
Market size · 2033$7.48Btotal addressable
Market CAGR7.3%2027–2033
Target share17.9%from 9.6% today
Revenue ambition$1.34Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.6% | 17.9% | On track |
| Revenue | $787M | $1.34B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.1% | 45.5% | At risk |
| Customer retention | 90.8% | 95.9% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $154M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Cell Culture Vessel Market conversation — a $4.00B market you can size, segment and defend in minutes.
Market size · 2033$4.00Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,439+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 3 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Corning IncorporatedThermo Fisher Scientific Inc.Sartorius AGMerck KGaA (MilliporeSigma)Greiner Bio-One International GmbHNunc (part of Thermo Fisher Scientific)CELLSTAR (Greiner Bio-One)SPL Life Sciences+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Cell Culture Vessel Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Cell Culture Vessel Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Cell Damage & Repair Market
Market size, share, segmentation and regional forecast.
$576M market · 2025 base year
View reportCell Dialyzerr Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportCell Disrupter Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportCell Disruptor Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportCell Imaging Systems Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportCell Isolation or Cell Separation Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportCell Leukodystrophy (Krabbe Disease) Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportCell Line and Identification Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportCell Line Toxicology Instruments Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportCell Lines Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportCell Phone Cellular Repeater Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportCell Phone Charger Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.